They agreed after talks between Kyiv and the Washington-based lender and the figure has been shared with the European ...
Referring to KBC Group’s earlier and repeated statements about its strategy, we remain committed to pursuing financially sound and sustainable growth. We are continuously monitoring the market to ...
Shares of electricity storage and software provider Fluence (NASDAQ:FLNC) jumped 12.9% in the morning session after the ...
The governments of Britain and the United States will set up a body to reduce red tape for firms seeking to access capital ...
(Reuters) -Bank of England Governor Andrew Bailey said on Monday that he and other regulators who oversee the financial ...
The potential financing doubles the Finnish company's valuation from the December figure of $5.2 billion, when it raised $200 million in a Series D funding round. Oura plans to use the funds to scale ...
The FTSE 100 was subdued while European stocks fell on Monday, as US stocks looked set to add to historic highs, at the start ...
BP has stopped work on its Rotterdam biofuels plant, a company spokesperson said on Monday, marking the latest in a string of ...
The US has all but stopped paying its bills to the United Nations since Trump took office in January and still has ...
Lumen Technologies (NYSE: LUMN) today announced significant progress in its multi-year effort to build the backbone for the ...
Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface ...
AstraZeneca Wins European Committee's Positive Opinion for Two Drugs Tackling Chronic, Rare Diseases
AstraZeneca (AZN.L, AZN.ST) won backing in Europe for two medicines that could transform treatment for patients suffering from difficult-to-treat conditions, according to press releases on Monday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results